Premium
Treatment of Pruritus in Hodgkin's Disease and in Reticulum Cell Sarcoma
Author(s) -
Bichel Jørgen,
Brincker Hans
Publication year - 1965
Publication title -
scandinavian journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0036-553X
DOI - 10.1111/j.1600-0609.1965.tb01283.x
Subject(s) - levomepromazine , medicine , sarcoma , disease , chemotherapy , reticulum cell sarcoma , radiation therapy , dermatology , pathology , haloperidol , dopamine
10 patients in whom pruritus was a very prominent symptom were treated with levomepromazine in daily doses of 25–50 mg. 7 of these patients suffered from Hodgkin's disease and 3 from reticulum cell sarcoma. In a number of patients levomepromazine controlled pruritus effectively without significant side‐effects. Though all the patients had other simultaneous treatments, e.g. radiation treatment or chemotherapy, the treatment with levomepromazine is considered to be the cause of relief of the pruritus in most of the patients.